Related Experiment Video
Updated: Jul 10, 2026

An Ex vivo Model to Study Hormone Action in the Human Breast
Published on: January 8, 2015
Extranuclear expression of hormone receptors in primary breast cancer
1International Radiation Information Center, Department of Pathology, Hiroshima Asa City Hospital and Hiroshima University Hospital, Japan. rkim@hiroshima-u.ac.jp
Background:
Hormone receptor (HR)-positive breast cancer cells grow through estrogen receptor (ER)-signaling pathways that mediate both genomic and nongenomic actions, which cross-talk with growth factors associated with resistance to tamoxifen. The aim of this study was to explore the cross-talk between extranuclear expression of ER and progesterone receptor (PR) and growth factor signaling pathways in primary breast cancer.
Patients And Methods:
The extranuclear expression of ER and PR was examined in 219 primary breast cancers by immunohistochemical staining. Specimens showing such expression were further examined for the expression of pAkt and aromatase. Staining reactions were scored on the basis of intensity and distribution in the tumors.
Results:
Extranuclear expression of ER or PR was observed in 21 cases (9.5%), which included four cases for ER and 20 cases for PR. Among these patients, HER-2, pAkt, and aromatase-positivity were observed in 14 cases (66.6%), 13 cases (61.9%), and 14 cases (66.6%), respectively. On the basis of nuclear HR expression, 11 of these cases were categorized as ER-positive/PR-negative, while two were ER-negative/PR-positive. Of these 13 cases, increased pAkt staining was found in 11 cases (84.6%). In particular, among the 11 ER-positive/PR-negative cases, elevated pAkt and aromatase were found in 10 (90.9%; P<0.01) and nine cases (81.8%), respectively.
Conclusions:
PR is expressed extranuclearly more frequently than ER in primary breast cancer, and extranuclear HRs cross-talk with the Akt/HER-2-signaling pathways and activation of aromatase. These observations may explain the more beneficial effects of aromatase inhibitors than tamoxifen for ER-positive/PR-negative patients.
Insights
Extranuclear progesterone receptor (PR) is more common than estrogen receptor (ER) in breast cancer, suggesting PR
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Hormone receptor (HR)-positive breast cancer growth involves estrogen receptor (ER) signaling.
- ER signaling has both genomic and nongenomic actions, interacting with growth factors.
- This interaction can lead to resistance to tamoxifen treatment.
Purpose of the Study:
- To investigate the cross-talk between extranuclear ER and progesterone receptor (PR) expression.
- To examine the relationship with growth factor signaling pathways in primary breast cancer.
Main Methods:
- Examined extranuclear ER and PR expression in 219 primary breast cancers using immunohistochemical staining.
- Assessed co-expression of pAkt and aromatase in specimens with extranuclear HR expression.
- Scored staining intensity and distribution for quantitative analysis.
Main Results:
- Extranuclear ER or PR expression found in 9.5% of cases (21/219).
- HER-2, pAkt, and aromatase positivity observed in 66.6%, 61.9%, and 66.6% of these cases, respectively.
- Elevated pAkt and aromatase were significantly associated with ER-positive/PR-negative cases (90.9% and 81.8%, respectively).
Conclusions:
- Extranuclear PR expression is more frequent than ER in primary breast cancer.
- Extranuclear HRs interact with Akt/HER-2 signaling pathways and aromatase activation.
- Findings may explain improved outcomes with aromatase inhibitors over tamoxifen in ER-positive/PR-negative patients.
Related Concept Videos
Endocrine Signaling
Intracellular Hormone Receptors
Internal Receptors
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the timing and level of...
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

